Sharon L Christ1, D Diane Zheng2, Bonnielin K Swenor3, Byron L Lam4, Sheila K West3, Stacey L Tannenbaum2, Beatriz E Muñoz3, David J Lee5. 1. Department of Human Development and Family Studies, Purdue University, West Lafayette, Indiana2Department of Statistics, Purdue University, West Lafayette, Indiana. 2. Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida. 3. Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida. 5. Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida5Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
Abstract
IMPORTANCE: Determination of the mechanisms by which visual loss increases mortality risk is important for developing interventional strategies. OBJECTIVE: To evaluate the direct and indirect effects of loss of visual acuity (VA) on mortality risk through functional status changes among aging adults. DESIGN, SETTING, AND PARTICIPANTS: Prospective longitudinal study of a population-based sample of 2520 noninstitutionalized adults aged 65 to 84 years from September 16, 1993, through July 26, 2003, in the greater Salisbury area of Maryland. Participants underwent reassessment 2, 6, and 8 years after baseline. Mortality status was ascertained from linkage with the National Death Index through 2009. EXPOSURES: Results of VA testing and self-reported functional status based on activities of daily living (ADL) and instrumental ADL (IADL). MAIN OUTCOMES AND MEASURE: Mortality. RESULTS: Worse VA levels at baseline were associated with an increased the risk for mortality (hazard ratio [HR], 1.16 [95% CI, 1.04-1.28]; P < .01) through their effect on lower IADL levels at baseline. Declines in VA over time were associated with increased mortality risk (HR, 1.78 [95% CI, 1.27-2.51]; P < .001) by way of decreasing IADL levels over time. Participants experiencing the mean linear decline in VA of 1 letter on the Early Treatment Diabetic Retinopathy Study acuity chart per year are expected to have a 16% increase in mortality risk during the 8-year study exclusively through associated declines in IADL levels. CONCLUSIONS AND RELEVANCE: In this longitudinal study of older adults, VA loss adversely affected IADL levels, which subsequently increased the risk for mortality. Prevention of disabling ocular conditions, treatment of correctable visual impairment, and interventions designed to prevent the effect of visual impairment on IADL declines may all reduce mortality risk in aging adults.
IMPORTANCE: Determination of the mechanisms by which visual loss increasesmortality risk is important for developing interventional strategies. OBJECTIVE: To evaluate the direct and indirect effects of loss of visual acuity (VA) on mortality risk through functional status changes among aging adults. DESIGN, SETTING, AND PARTICIPANTS: Prospective longitudinal study of a population-based sample of 2520 noninstitutionalized adults aged 65 to 84 years from September 16, 1993, through July 26, 2003, in the greater Salisbury area of Maryland. Participants underwent reassessment 2, 6, and 8 years after baseline. Mortality status was ascertained from linkage with the National Death Index through 2009. EXPOSURES: Results of VA testing and self-reported functional status based on activities of daily living (ADL) and instrumental ADL (IADL). MAIN OUTCOMES AND MEASURE: Mortality. RESULTS: Worse VA levels at baseline were associated with an increased the risk for mortality (hazard ratio [HR], 1.16 [95% CI, 1.04-1.28]; P < .01) through their effect on lower IADL levels at baseline. Declines in VA over time were associated with increased mortality risk (HR, 1.78 [95% CI, 1.27-2.51]; P < .001) by way of decreasing IADL levels over time. Participants experiencing the mean linear decline in VA of 1 letter on the Early Treatment Diabetic Retinopathy Study acuity chart per year are expected to have a 16% increase in mortality risk during the 8-year study exclusively through associated declines in IADL levels. CONCLUSIONS AND RELEVANCE: In this longitudinal study of older adults, VA loss adversely affected IADL levels, which subsequently increased the risk for mortality. Prevention of disabling ocular conditions, treatment of correctable visual impairment, and interventions designed to prevent the effect of visual impairment on IADL declines may all reduce mortality risk in aging adults.
Authors: Sharon L Christ; David J Lee; Byron L Lam; D Diane Zheng; Kristopher L Arheart Journal: Invest Ophthalmol Vis Sci Date: 2008-03-24 Impact factor: 4.799
Authors: S R Cummings; M C Nevitt; W S Browner; K Stone; K M Fox; K E Ensrud; J Cauley; D Black; T M Vogt Journal: N Engl J Med Date: 1995-03-23 Impact factor: 91.245
Authors: Sharon H Saydah; Robert B Gerzoff; Jinan B Saaddine; Xinzhi Zhang; Mary Frances Cotch Journal: JAMA Ophthalmol Date: 2020-05-01 Impact factor: 7.389
Authors: Xiaoling Xiang; Vicki A Freedman; Khushali Shah; Rita X Hu; Brian C Stagg; Joshua R Ehrlich Journal: J Gerontol A Biol Sci Med Sci Date: 2020-02-14 Impact factor: 6.053
Authors: D Diane Zheng; Sharon L Christ; Byron L Lam; Stacey L Tannenbaum; Christine L Bokman; Kristopher L Arheart; Laura A McClure; Cristina A Fernandez; David J Lee Journal: Invest Ophthalmol Vis Sci Date: 2014-07-24 Impact factor: 4.799
Authors: A Hajek; C Brettschneider; D Lühmann; M Eisele; S Mamone; B Wiese; S Weyerer; J Werle; M Pentzek; A Fuchs; J Stein; T Luck; H Bickel; D Weeg; K Heser; F Jessen; W Maier; M Scherer; S G Riedel-Heller; H-H König Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Soo Khai Ng; Shyalle Kahawita; Nicholas Howard Andrew; Tim Henderson; Jamie Evan Craig; John Landers Journal: JAMA Ophthalmol Date: 2018-05-01 Impact factor: 7.389
Authors: Rachel O'Conor; Samuel G Smith; Laura M Curtis; Julia Yoshino Benavente; Daniel P Vicencio; Michael S Wolf Journal: J Aging Health Date: 2016-11-10
Authors: D Diane Zheng; Christine L Bokman; Byron L Lam; Sharon L Christ; Bonnielin K Swenor; Sheila K West; Beatriz E Muñoz; Stacey L Tannenbaum; David J Lee Journal: Aging Ment Health Date: 2015-02-12 Impact factor: 3.658
Authors: Mary E Fischer; Karen J Cruickshanks; Carla R Schubert; Alex A Pinto; Cynthia M Carlsson; Barbara E K Klein; Ronald Klein; Ted S Tweed Journal: J Am Geriatr Soc Date: 2016-09-09 Impact factor: 5.562
Authors: Laura A McClure; D Diane Zheng; Byron L Lam; Stacey L Tannenbaum; Charlotte E Joslin; Sonia Davis; Daniel López-Cevallos; Marston E Youngblood; Zhu-Ming Zhang; Claudia Pulido Chambers; David J Lee Journal: JAMA Ophthalmol Date: 2016-03 Impact factor: 7.389